BREAKING
CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 33 minutes ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 12 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 13 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 16 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 18 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 19 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 22 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 24 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 day ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 1 day ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 33 minutes ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 12 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 13 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 16 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 18 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 19 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 22 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 24 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 day ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 1 day ago
ADVERTISEMENT
Market News

Earnings Summary: Eastman Chemical Company (EMN) Q2 2023 results

Eastman Chemical Company (NYSE: EMN) reported lower sales and adjusted profit for the second quarter of 2023. The management provided guidance for the full fiscal year. Total sales revenue decreased to $2.32 billion in the second quarter from $2.78 billion in the corresponding period of 2022 The chemical company reported adjusted earnings of $1.99 per […]

$EMN July 31, 2023 1 min read

Eastman Chemical Company (NYSE: EMN) reported lower sales and adjusted profit for the second quarter of 2023. The management provided guidance for the full fiscal year.

  • Total sales revenue decreased to $2.32 billion in the second quarter from $2.78 billion in the corresponding period of 2022
  • The chemical company reported adjusted earnings of $1.99 per share for the three-month period, lower than the $2.83 per share profit it reported a year earlier
  • Unadjusted profit, on a per-share basis, came in at $2.27, compared to $2.03 in the prior-year quarter
  • Net cash provided by operating activities was $410 million in the second quarter, vs. $245 million last year
  • Q2 adjusted EBITDA decreased to $336 million from $469 million in the year-ago period
  • The company said it expects the auto, aviation, and other markets to modestly improve in the second half of the year
  • Eastman is looking for earnings in the range of $6.50 per share to $7.00 per share for fiscal 2023
  • It continues to expect to generate $1.4 billion of operating cash flow this year
ADVERTISEMENT